Differential Scanning Fluorimetry (Thermal Shift) Screen of Buffer and Ligand Stabilization for a Purified Kinase Domain

96-well plate format, 20 µL reactions, each condition in technical triplicate. Arm 1 (buffer screen): a 24-condition pH/salt/additive matrix at fixed protein (5 µM) and SYPRO Orange (5×). Arm 2 (ligand dose-response): apo plus a 6-point ligand dilution series (e.g. 0, 1, 3, 10, 30, 100 µM) in the best buffer, with a DMSO-vehicle-matched series. Melt from 25 °C to 95 °C at 1 °C/min with continuous fluorescence acquisition. Buffer-only and dye-only blanks included.

BSL-1 for recombinant protein. Hazards: SYPRO Orange is supplied in DMSO (a potent skin-penetrant carrier — handle test compounds dissolved in DMSO with care, as DMSO enhances dermal absorption of co-dissolved chemicals); TCEP and buffer components are mild irritants. PPE: lab coat, nitrile gloves, safety glasses. Treat unknown screening compounds as hazardous; collect DMSO/compound waste as chemical waste. No high-voltage or biohazard beyond standard.

Apo (no-ligand) protein in the assay buffer is the reference Tm for all ΔTm calculations. Vehicle control: DMSO-only at matched final concentration, to subtract any solvent effect on Tm. Dye-only and buffer-only blanks: detect intrinsic dye fluorescence/precipitation. Positive control ligand: a known binder expected to stabilize (positive ΔTm). Negative control compound: a structurally similar non-binder expected to give ΔTm ≈ 0.

A single sigmoidal fluorescence transition; the first-derivative minimum or Boltzmann inflection gives Tm. Apo Tm typically 40-60 °C for a kinase domain. Stabilizing buffers raise Tm by +2 to +10 °C; a true binder produces a dose-dependent positive ΔTm of +1 to +8 °C, plateauing at saturation. The non-binder gives ΔTm within ±0.5 °C. High initial fluorescence or biphasic curves flag aggregation/misfolding.

• Purified target protein (kinase domain), 0.2-1 mg/mL stock in storage buffer
• SYPRO Orange protein gel stain, 5000× concentrate (diluted to 5× final)
• Buffer screen matrix: 100 mM buffers spanning pH 5.5-9.0 (citrate, MES, HEPES, Tris, CHES), 0-500 mM NaCl, ± 5% glycerol, ± 1 mM TCEP/MgCl2
• Test ligand stock (e.g. ATP-competitive inhibitor), 10 mM in 100% DMSO
• Non-binding control compound, 10 mM in DMSO
• 96-well white/clear hard-shell qPCR plate + optical adhesive seal
• DMSO for vehicle matching (final ≤2% v/v)

To measure the thermal unfolding transition (Tm) of a purified protein by monitoring SYPRO Orange fluorescence as the dye binds exposed hydrophobic core upon thermal denaturation in a real-time PCR instrument. The objective is two-fold: rank a panel of buffers/additives by stabilization (ΔTm), and confirm ligand binding via a dose-dependent positive Tm shift relative to apo protein.

1. Thaw protein on ice; clarify by spinning 10 min, 20,000 × g, 4 °C to remove aggregates.
2. Prepare a 2× SYPRO Orange working solution (10×) in each test buffer.
3. In each well combine protein (final 5 µM), SYPRO Orange (final 5×), buffer/additive or ligand to 20 µL. Keep DMSO constant (≤2%) across ligand and vehicle wells.
4. Centrifuge the sealed plate 2 min, 1,000 × g to remove bubbles.
5. Load into a real-time PCR/qPCR instrument; set the melt: 25→95 °C at 1 °C/min, acquiring in the ROX/TAMRA channel (ex ~470 nm / em ~570 nm) every 0.5-1 °C.
6. Run buffer-only and dye-only blanks for background.
7. Export raw fluorescence vs temperature for all wells.
8. Repeat the full plate on n=3 independent protein aliquots.

Independent: buffer composition (pH, salt, additives) in Arm 1; ligand concentration in Arm 2. Dependent: melting temperature Tm and ΔTm (condition Tm − apo Tm). Controlled: protein concentration (5 µM), SYPRO Orange (5×), DMSO (≤2% constant), heating rate (1 °C/min), instrument channel, and well volume (20 µL).

A folded, well-behaved kinase domain will display a single cooperative sigmoidal melt transition. We hypothesize that (i) optimal pH/salt/additive conditions will raise Tm relative to a baseline buffer, and (ii) a specific ATP-competitive ligand will produce a concentration-dependent positive ΔTm (ligand engagement), whereas a non-binding control compound will not.

Tm determined as the inflection point of the melt curve, either by fitting raw fluorescence to a Boltzmann sigmoid or by taking the minimum of the negative first derivative (−dF/dT) in DSF analysis software (e.g. Protein Thermal Shift, DSFworld, or NAMI). Pre-transition baseline and post-peak quench regions excluded. ΔTm = Tm(condition) − Tm(apo). Dose-response ΔTm vs [ligand] fit to estimate apparent binding.

1. High initial fluorescence / no transition: protein already partially unfolded or aggregated, or dye binds folded surface — clarify protein, lower dye to 2.5×, or try a different additive. 2. Flat/no melt: dye photobleached or Tm >95 °C — use fresh dye, extend range. 3. Biphasic curves: multidomain protein or mixed oligomeric states — note both transitions, polish by SEC. 4. Noisy/jagged derivative: bubbles or low protein — spin plate, increase protein to 10 µM. 5. Vehicle shifts Tm: DMSO too high — cap at ≤2% and match across all wells.

Tm per condition reported as mean ± SD of technical triplicates and across n=3 protein lots. ΔTm significance vs apo tested by one-way ANOVA with Dunnett's correction (each condition vs the apo control), α=0.05. Ligand-vs-vehicle comparison by two-tailed t-test. Replicate Tm SD is typically <0.5 °C; this resolves ΔTm ≥1 °C as significant with n=3.